BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:New trends in Immuno-Oncology - towards personalised cancer treatm
 ent - Markus Zettl - CureVac
DTSTART:20230518T113000Z
DTEND:20230518T130000Z
UID:TALK199510@talks.cam.ac.uk
CONTACT:90994
DESCRIPTION:Markus Zettl\, PhD has more than 15 years experience in resear
 ch and development in the area of Immuno-Oncology bringing multiple drug c
 andidates to the clinic as well as providing preclinical and translational
  support for Phase 1 to 2 clinical studies. Before joining CureVac as Vice
  President leading the Oncology Research & Development organisation\, he w
 orked at Boehringer Ingelheim and the mid-size Pieris Pharmaceuticals. Fur
 thermore\, he held academic positions at the Laboratory of Molecular Biolo
 gy (LMB) Cambridge and performed his Ph.D at the European Molecular Biolog
 y Laboratory (EMBL) Heidelberg and CRUK\, London. Throughout his career he
  published several high impact publications including Cell and Science and
  is an inventor on multiple patents.
LOCATION:Jean Thomas Lecture theatre\, Sanger Building\, Tennis Court Road
END:VEVENT
END:VCALENDAR